The anarchist grew animated as he explained his plan to subvert a pillar of global capitalism by teaching the poor to make their own medicines — pharmaceutical industry patents be damned.
Then he took another sip from a flute of Taittinger Champagne.
Swaggering, charismatic, and complex, Michael Laufer has become a fixture in the growing biohacker movement ever since he published plans last year for a do-it-yourself EpiPencil — a $35 alternative to the pricey EpiPen.
It’s not clear whether anyone has actually ever used a homemade EpiPencil to prevent anaphylactic shock. But that seems almost an afterthought to Laufer’s bigger goal — trying to build a DIY movement to attack high pharma pricing and empower patients.
The de facto leader behind the leaderless collective Four Thieves Vinegar, Laufer is now on to his next project: He’s developing a desktop lab and a recipe book meant to equip patients to cook up a range of medicines, including a homemade version of the expensive hepatitis C drug Sovaldi, on their kitchen counters.
Health professionals have strenuously warned against DIY pharmaceuticals, but Laufer sees his work as a moral crusade against the patent laws and market forces that let drug companies price vital remedies out of reach for many patients.
“To deny someone access to a lifesaving medication is murder,” he said. And “an act of theft [of intellectual property] to prevent an act of murder is morally acceptable.”
The trade group PhRMA has so far ignored Laufer and declined to comment on his work. Regulators at the Food and Drug Administration haven’t bothered him, either. But in an era when a year’s worth of medicine can cost U.S. patients $750,000, Laufer believes his message is starting to resonate. And even some who call his approach irresponsible and dangerous acknowledge that it’s hard to dismiss Laufer outright.
“Desperate times call for desperate measures,” said Dr. Vinay Prasad, a professor at Oregon Health and Science University.
Prasad is no friend of the drug industry, but he considers it foolhardy for patients to try to make their own medicines. Still, he said the emergence of Laufer, or someone like him, was inevitable: “He’s another symptom of the disease, and the disease is drug pricing.”
Connect With Us